Janux Therapeutics Inc (JANX)
37.63
-0.29
(-0.76%)
USD |
NASDAQ |
Mar 28, 16:00
37.63
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics Total Liabilities (Quarterly): 36.06M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.06M |
September 30, 2023 | 37.90M |
June 30, 2023 | 42.03M |
March 31, 2023 | 41.69M |
December 31, 2022 | 43.27M |
September 30, 2022 | 44.24M |
June 30, 2022 | 41.55M |
Date | Value |
---|---|
March 31, 2022 | 12.52M |
December 31, 2021 | 13.50M |
September 30, 2021 | 14.33M |
June 30, 2021 | 12.03M |
March 31, 2021 | 88.59M |
December 31, 2020 | 30.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.03M
Minimum
Jun 2021
88.59M
Maximum
Mar 2021
35.27M
Average
37.90M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
Viking Therapeutics Inc | 20.07M |
Equillium Inc | 27.96M |
Minerva Neurosciences Inc | 85.36M |
Geron Corp | 146.13M |
Calidi Biotherapeutics Inc | 18.25M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 380.41M |
Shareholders Equity (Quarterly) | 344.35M |
Current Ratio | 26.80 |